Abstract:Objective To study the long-term results of mechanical valve replacement, bioprosthetic valve replacement or valve plasty in elderly patients with mitral valve disease. Methods From January 2006 to December 2008, 116 cases, received mitral valve surgery and were discharged. Among all the patients, 76 cases suffered from rheumatic mitral valve disease, 40 cases suffering from mitral degenerative disease. Mechanical valve replacement was carried out in 62 cases, biological valve replacement in 34 cases and mitral valvuloplasty in 20 cases. The events of death, reoperation, infective endocarditis, paravalvular leakage, cardiac function, anticoagulation,bleeding events, thromboembolism were recorded by outpatient clinic interview or telephone follow-up. Results 116 patients were followed up for 24 to 60 months and the mean time of follow-up was 48.4 ± 10.7 months.During the follow-up, mitral valve function was good in 20 cases of valvuloplasty and there were no deaths, moderate regurgitation, readmission, reoperation, and other adverse events. Biological valves function were normal in 34 cases of biological valve replacement, and during follow-up period the poatieuts aspirin was used to prevent coagulation. There were no valve decline and no adverse events. The cardiac function was significantly improved. All 62 cases of mechanical valve replacement were taking warfarin with good mechanical valve function and the heart function improved significantly. The events of infective endocarditis, paravalvular leakage, bleeding and thromboembolism occured. Conclusions Surgical treatment of mitral valve disease in elderly patients could significantly improve cardiac function and prolong survival time. However, the long-term effects of different surgical procedures have some differences. Valvuloplasty could avoid the application of anticoagulation drugs. Biological valve replacement can be as good as valvuloplasty, but biological decay may lead to re-operation in the relatively low-age patients. Mechanical valve replacement requires lifelong anticoagulation therapy, and the main factors affecting the long-term effects are bleeding and thrombotic complications.

Valve Replacement for Valvular Heart Disease with Giant Left Ventricle.

[Surgical Treatment of Tricuspid Valve Disease Combined with Cardiac Cachexia Syndrome].

Diagnosis and surgical treatment of cardiac valve injury

Results of surgical treatment in valve disease in 70 patients

Clinical Study of the Efficacy of Different Types of Surgery in Elderly Patients with Mitral Valve Disease

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Rare Quadricuspid Aortic Valve with Acute Early Incapacitation

Update of Transcatheter Valve Treatment

The Analysis of Reoperation after Mechanical Valve Prosthesis Replacement

Behavior of the thyroid toward elements of the seventh periodic group.

Quadruple valve replacement with mechanical valves: an 11-year follow-up study

Aortic valve replacement in elderly patients:Surgical risk and outcome

LONG-TERM FOLLOW UP OF 351 CASES OF HEART VALVE REPLACEMENT WITH BIOPROSTHESES

Transapical aortic valve implantation using J-Valve? system for high-risk patients with aortic regurgitation: mid-stage of 1 year follow-up

Short-Term Outcomes after Transcatheter Aortic Valve Replacement in Predominant Aortic Regurgitation with Left Ventricular Dysfunction.

Midterm Outcome of Valve Repair for Rheumatic Mitral Stenosis: 6-year Experience in a Single Mid-Volume Cardiac Center

Perioperative Management of 310 High Risk Patients with Valvular Heart Disease

Transapical Transcatheter Valve Replacement Using J-Valve for Aortic Valve Diseases

Doppler Echocardiographyic Evaluation of Heart Function in Patients with Small Aortic Vale Replacement

Efficacy of Double Valve Replacement/Repair in Patients with Reduced Left Ventricular Ejection Fractions

Comparing Study of Heart Function of Biological Valves Replacement with Mechanical Valves Replacement in Patients with Small Aortic Root